Ümmügülsüm GÜMÜŞ, Gülbin ŞENNAZLI, Utku BAKIREL

The protective and therapeutic effect of phenoxy-2-methyl-2-propionic acid on experimental fatty liver in rats

In this study, the potential protective and therapeutic effect of phenoxy-2-methyl-2-propionic acid (PMPA) was investigated in rats with experimental hepatic steatosis induced by a carbon tetrachloride and paraffin liquid mixture (1:1). Forty Wistar albino rats were allocated to 4 groups with 10 rats in each. Group 1 was administered a saline solution; group 2 was administered the carbon tetrachloride and paraffin liquid mixture; group 3 was administered the carbon tetrachloride and paraffin liquid mixture and PMPA for 7 days; and in group 4, hepatic steatosis was created with the carbon tetrachloride and paraffin liquid mixture during the first 7 days, after which the rats were administered only PMPA during the last 7 days. All injections were done intraperitoneally. Blood samples were obtained from all rats and livers were extirpated before euthanasia. Blood parameters were found to be significantly different between the groups (P < 0.05). On histopathologic examination, grade 1 hepatic steatosis was observed in group 1; grade 3 hepatic steatosis and grade 2 portal fibrosis were observed in group 2; grade 2 hepatic fibrosis and grade 1 portal fibrosis were observed in group 3; and grade 1 hepatic steatosis was observed in group 4. Hepatic fibrosis was induced in the rats using a carbon tetrachloride and paraffin liquid mixture. Results indicated that PMPA has a limited protective effect and a superior therapeutic effect on hepatic steatosis.

Anahtar Kelimeler:

Key words: Hepatic steatosis, rat, phenoxy-2-methyl-2-propionic acid, histopathologic examination, blood parameters

The protective and therapeutic effect of phenoxy-2-methyl-2-propionic acid on experimental fatty liver in rats

Keywords:

Key words: Hepatic steatosis, rat, phenoxy-2-methyl-2-propionic acid, histopathologic examination, blood parameters,

PDF

___

Holan KM. Feline hepatic lipidosis. In: Bonagura JD, Twedt DC, editors. Kirk’s Current Veterinary Therapy. 14th ed. St Louis, MO, USA: Saunders Elsevier; 2009. pp. 570–575.
Scherk MA, Center SA. Toxic, metabolic, infectious, and neoplastic liver disease. In: Ettinger SJ, Feldman EC, editors. Textbook of Veterinary Internal Medicine. St Louis, MO, USA: Saunders Elsevier; 2010. pp. 1672–1689.
Burrows CF. Liver disorders. In: Schaer M, editor. Clinical Medicine of the Dog and Cat. London, UK: Manson; 2003. pp. 340–349.
Turgut K, Ok M. Hepatik lipidozis. Karaciğer hastalıkları. In: Kedi ve Köpek Gastroenterolojisi Semptomdan Teşhise. Konya, Turkey: Bahçıvanlar Basım San.; 2001. pp. 445–546 (book chapter in Turkish).
Fusai G, Glantzounis GK, Hafez T, Yang W, Quaglia A, Sheth H, Kanoria S, Parkes H, Seifalian A, Davidson BR. N-Acetylcysteine ameliorates the late phase of liver ischaemia/ reperfusion injury in the rabbit with hepatic steatosis. Clin Sci 2005; 109: 465–473.
Isselbacher KL, Podolsky DK. Hepatic steatosis (fatty liver) and steatohepatitis infiltrative and metabolic diseases affecting the liver. In: Fauci AS, editor. Harrison’s Principles of Internal Medicine. 14th ed. New York, NY, USA: McGraw-Hill; 1998. pp. 1717–1720.
Farina R. Peroxisome proliferator-activated receptor alpha: a new target for metabolic disorders of dairy cows. In: Proceedings from the XXIX Congreso Nacional de Buiatria. Puebla, Mexico; 2005.
Chícharo CH. Determination of the levels of cholesterol and triglycerides in dairy cows after the preventive administration of phenoxy-2-methyl-2-propionic sodium acid. In: Proceedings from the XXXI Congreso Nacional de Buiatria y XIII Congreso Latinoamericano de Buiatria. Acapulco, Mexico; 2007.
Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 1999; 94: 2467–2474.
Düzgüneş O, Kesici T, Kavuncu O, Gürbüz F. Araştırma ve deneme metodları (istatistik metodları - 1). Ankara Üniv Zir Fak Yay 1987; 1021 (article in Turkish).
Erdogan HM, Citil M, Tuzcu M, Atakisi E, Gunes V, Uzlu E. The effect of L-carnitine administration on doxorubicine induced hepatoxicity and nephrotoxicity in rabbits. Kafkas Univ Vet Fak Derg 2009; 15: 733–738.
Fujita K, Yoneda M, Wada K, Mawatari H, Takahashi H, Kirikoshi H, Inamori M, Nozaki Y, Maeyama S, Saito S et al. Telmisartan, an angiotensin II type 1 receptor blocker, controls progress of nonalcoholic steatohepatitis in rats. Dig Dis Sci 2007; 52: 3455–3464.
Fang YL, Liang L, Fu JF. Establishment of rabbit model of juvenile nonalcoholic steatohepatitis. Zhejiang Da Xue Xue Bao Yi Xue Ban 2008; 37: 240–244.
Li JZ, Ye J, Xue B, Qi J, Zhang J, Zhou Z, Li Q, Wen Z, Li P. Cideb regulates diet-induced obesity, liver steatosis, and insulin sensitivity by controlling lipogenesis and fatty acid oxidation. Diabetes 2000; 56: 2523–2532.
Birkner E, Zalejska-Fiolka J, Kasperczyk A, Kasperczyk S, Grucka-Mamczar E, Stawiarska-Pięta B, Birkner K. The influence of methionine, selenomethionine, and vitamin E on liver metabolic pathways and steatosis in high-cholesterol fed rabbits. Biol Trace Elem Res 2007; 120: 179–194.
Karataş F, İnanç F, Gür B, Canatan H, Halifeoğlu İ, Bakan İ. Examination of serum orotic acid levels in experimental cirrhosis. Fırat Üni Sağlık Bil Derg 2002; 16: 263–266.
Kapuściński J, Kuroszczyk J, Liniecki J, Bieńkiewicz M, Zieliński K, Tuszyner K. Experimental toxic liver damage and hepatic plasma clearance of 99mTc-mebrofenin (iminodiacetate derivative). I. Early, acute CCl 4 -induced liver damage in rabbits. Pol J Occup Med Environ Health 1993; 6: 169–183.
Yanni AE, Agrogiannis G, Nomikos T, Fragopoulou E, Pantopoulou A, Antonopoulou S, Perrea D. Oral supplementation with L-aspartate and L-glutamate inhibits atherogenesis and fatty liver disease in cholesterol-fed rabbit. Amino Acids 2010; 38: 1323–1331.
Sciorsci RL. Metabolism and reproductive parameters in cows during the post-partum. Postpartum in dairy cow: impact of the phenoxy-2-methyl-2-propionic sodium (HEPAGEN®, FATRO) on progesterone serum level. In: Proceedings of the 11th Congresso Nazionale Multisala, Italy: SIVAR; 2009.
Luo J, Xu H, Liu Y. An experimental rabbit model of hepatic fibrosis induced by high-sucrose/high-fat diet. J Changsha Med Coll 2006; 2006: 02.
Birkner E, Kasperczyk S, Kasperczyk A, Zalejska-Fiolka J, Zwirska-Korczala K, Stawiarska-Pieta B, Grucka-Mamczar E. Metabolic and antioxidative changes in liver steatosis induced by high-fat, low-carbohydrate diet in rabbits. J Physiol Pharm 2005; 56: 45–58.
Feldstein AE, Canbay A, Guicciardi ME, Higuchi H, Bronk SF, Gores GJ. Diet associated hepatic steatosis sensitizes to Fas mediated liver injury in mice. J Hepatol 2003; 39: 978–983.
Wu J, Hong L, Cai W, Tang Q, Shi C. Glutamine attenuates TPN-associated liver injury in infant rabbits. Eur J Pediatr 2007; 166: 601–606.
Fujita K, Nozaki Y, Wada K, Yoneda M, Endo H, Takahashi H, Iwasaki T, Inamori M, Abe Y, Kobayashi N et al. Effectiveness of antiplatelet drugs against experimental non-alcoholic fatty liver disease. Gut 2008; 57: 1583–1591.
Bayram İ, Özbek H, Uğraş S, Tüncer İ, Reçber D. Hepatoprotective effect of ascorbic acid and alpha tocopherol in carbon tetrachloride-induced acute hepatotoxicity. Van Tıp Dergisi 2004; 11: 32–38 (article in Turkish with abstract in English).
Şahin A, Yener Z, Dağoğlu G, Dede S, Oto G, Alkan M. The effect of nigella sativa (black chia seed) and vit. E + selenium in the prevention of liver necrosis experimentally induced with carbon tetrachloride (CCl 4 ) in rats. Türk J Vet Anim Sci 2003; 27: 141–152 (article in Turkish with abstract in English).
Kainuma M, Fujimoto M, Sekiya N, Tsuneyama K, Cheng C, Takano Y, Terasawa K, Shimada Y. Cholesterol-fed rabbit as a unique model of nonalcoholic, nonobese, non-insulin-resistant fatty liver disease with characteristic fibrosis. J Gastroenterol 2006; 41: 971–980.
Otogawa K, Kinoshita K, Fujii H, Sakabe M, Shiga R, Nakatani K, Ikeda K, Nakajima Y, Ikura Y, Ueda M et al. Erythrophagocytosis by liver macrophages (Kupffer cells) promotes oxidative stress, inflammation, and fibrosis in a rabbit model of steatohepatitis. Am J Pathol 2007; 170: 967– 9